Sort   by:  
 Page size 
UnknownLow- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Not available
S-EPMC9509410 | biostudies-literature
UnknownDairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies.
Not available
S-EPMC4037857 | biostudies-literature
UnknownDifferentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.
Not available
S-EPMC11408082 | biostudies-literature
UnknownREGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Not available
S-EPMC8522800 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownPeriventricular hyperintensities are associated with elevated cerebral amyloid.
Not available
S-EPMC4753726 | biostudies-literature
UnknownEffect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC9857647 | biostudies-literature
UnknownAssociation with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Not available
S-EPMC9307311 | biostudies-literature
UnknownOutpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
Not available
S-EPMC11141865 | biostudies-literature
UnknownStroke With Transfusions Changing to Hydroxyurea (SWiTCH).
Not available
S-EPMC3350359 | biostudies-literature
Sort   by:  
 Page size